Diseases, Conditions, Syndromes

We have a vaccine for hepatitis B, but we still need a cure

Hepatitis B is blood-borne virus that packs a punch. Worldwide, more than 1.3 billion people have been infected with hepatitis B, and 257 million people have developed a life-long infection. This includes 240,000 Australians, ...

Diseases, Conditions, Syndromes

FDA warns of liver problems for some taking hep C drugs

(HealthDay)—Taking the hepatitis C drugs Mavyret, Zepatier or Vosevi can trigger rare cases of severe liver problems or liver failure in patients who already have moderate-to-severe liver impairment, the U.S. Food and Drug ...

Medications

Expert applauds new draft recommendation for HCV screening

A new draft recommendation for hepatitis C virus (HCV) that recommends screening for adults ages 18 to 79 is exactly what's needed to address the dramatic increase in incidence of the disease, according to a University at ...

Medications

DAAs cut deaths in those treated for HCV-related liver cancer

(HealthDay)—Among patients with hepatitis C virus (HCV) infection and complete response to hepatocellular carcinoma (HCC) treatment, direct-acting antiviral (DAA) therapy is associated with a significant reduction in the ...

Obstetrics & gynaecology

Preventing hepatitis C transmission from mothers to babies

Hepatitis C virus (HCV) transmission from mothers to babies could largely be prevented if Canada recommended universal screening for HCV in pregnancy, argues a commentary in CMAJ (Canadian Medical Association Journal).

page 11 from 40